デフォルト表紙
市場調査レポート
商品コード
1351121

腎瘻デバイス市場の2030年までの予測- 製品タイプ別、エンドユーザー別、地域別の世界分析

Nephrostomy Devices Market Forecasts to 2030 - Global Analysis By Product Type, End User, and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 175+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
腎瘻デバイス市場の2030年までの予測- 製品タイプ別、エンドユーザー別、地域別の世界分析
出版日: 2023年09月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界の腎瘻デバイス市場は2023年に15億50万米ドルを占め、2030年には28億8,710万米ドルに達すると予測され、予測期間中のCAGRは9.8%です。

腎臓から尿を排出するには、腎瘻チューブと呼ばれる細く柔軟なチューブを皮膚から挿入します。このチューブは、閉塞したおしっこを一時的に排出するために利用されます。体外ではビニール袋がチューブに接続され、体液が回収されます。腎瘻は腎臓を健康に保ち、損傷や感染から守るのに役立ちます。また、腎瘻を造設すれば、超音波検査、X線検査、造影剤注入などで尿管を確認できるため、根本的な問題の診断にも役立ちます。

カナダ腎臓財団によると、腎臓結石はカナダでは一般的であり、特に過去25年間で増加傾向にあるようです。男性の約12%、女性の約6%が、人生のどこかで腎臓結石を経験するといわれています。

泌尿器科疾患の増加

水腎症、腎結石、尿閉、膀胱がん、前立腺がんなどの泌尿器科疾患の発生率の増加、経皮的腎瘻治療の増加は、予測期間を通じて市場に影響を与える主な要因です。さらに、老年人口は失禁、消化困難、慢性疾患など、長期ケアが必要な慢性疾患にかかりやすくなっています。そのため、世界の高齢者人口の増加が大きな影響力を持つ原動力になると予想されます。さらに、泌尿器科手術の件数は高齢化とともに増加し、これが市場成長の原動力となります。

否定的な結果をもたらす

頻繁に懸念されるのは、腎瘻チューブを留置する場所での感染です。ヘルスケア専門家は、治療中の無菌手順の採用や、患者への正しいケアとメンテナンスの指示など、このリスクを低減するための予防策を講じています。腎瘻造設術中または術後には出血が起こる可能性があり、これは例外的な状況で起こりうるため、追加の医療処置が必要となります。ドレッシング材や腎瘻チューブの成分にアレルギー反応を起こす人もいます。腎瘻チューブが不要になると、抜去部位にわずかな出血、不快感、痛みが生じることがあり、市場の成長を妨げます。

最小侵襲手術に対する需要の高まり

予測期間中、侵襲性の低い手術に対する需要の増加や、成功率の高い腎瘻デバイスの技術開発などの要因が市場を牽引します。腎臓の閉塞や感染症による痛みを経験している患者にとって、腎瘻は腎臓の圧力を緩和し炎症を抑えることで、痛みを大幅に緩和することができます。また、腎臓が老廃物をろ過し、体液バランスを維持し続けることができるため、市場成長のための幅広い機会が創出されます。

代替手技の利用可能性

腎瘻造設術の代替術式が利用できるようになると、患者ケアにプラス面でもマイナス面でも影響を与える可能性があります。患者のニーズや病状を慎重に評価することなく別の術式が選択される可能性があり、患者のケアに潜在的なリスクを伴うからです。その結果、理想的な結果が得られなかったり、困難が生じたりして、適切でない処置をとることになるかもしれないです。ヘルスケア専門家の経験やリソースの利用しやすさなど様々な要因が、代替手術の質に大きな影響を与える可能性があります。

COVID-19の影響:

COVID-19の最初の波は、世界の封鎖によってもたらされた腎臓内科関連の処置や診察の遅れにより、腎瘻デバイス市場に大きな影響を与えました。COVID-19の大流行により、世界中の泌尿器科はリソースとマンパワーの不足のために診療の再編成を余儀なくされました。しかし、規制が緩和されるにつれて、腎疾患の増加や腎瘻デバイスの使用の増加により、市場は今後数年間で拡大すると予想されます。

予測期間中はガイドワイヤーセグメントが最大になる見込み

ガイドワイヤーセグメントは、さまざまな管腔構造にアクセスし、通過を助ける能力があるため、大きな成長が見込まれます。ガイドワイヤーは効果的な器具です。診断や介入処置の際に泌尿器用具の配置を容易にするために、泌尿器用ガイドワイヤーが使用されます。腎臓の問題や低侵襲の腎臓病メーカーへの要望の高まりにより、腎結石障害の発生率の上昇、卵巣、膀胱、前立腺の悪性腫瘍の頻発、侵襲の少ない外科治療への要望の高まりが、腎瘻造設術中のガイドワイヤーの必要性を高めると予想され、市場の拡大を促すと予測されています。

予測期間中、外来手術センター分野が最も高いCAGRが見込まれる

外来手術センター部門は、病院や他のヘルスケア環境と比較して、より個別化されたサービスを提供し、より大きな成果を上げていることから、予測期間中に最も高いCAGRを記録すると予測されています。さらに、ASCは様々な疾患や障害の治療という問題に対処する必要がなく、患者がより良い患者体験とともにオーダーメイドのケアを受けられることを保証できるため、市場の成長が促進されます。

最大のシェアを占める地域:

北米は、有利な償還規則、製品認知度の上昇、高度な資格を持つ医師の確保、同地域に確立されたヘルスケア施設の存在などにより、予測期間中に最大の市場シェアを占めると予測されます。技術的に改良された医療用品の急速な普及に加え、同地域における腎結石の有病率の上昇が腎瘻デバイスの需要を増加させると予想されます。

CAGRが最も高い地域:

アジア太平洋地域は、病院、診療所、泌尿器科専門センターなどの医療施設の設立により、予測期間中のCAGRが最も高くなると予測されています。これにより、腎瘻手術を必要とする人々がヘルスケアサービスをより利用しやすくなり、腎瘻デバイスのニーズが高まっています。さらに、地方自治体は法律を制定し、ヘルスケアシステムをアップグレードし、最先端の医療技術の使用を促進する取り組みを開始しています。これにより、泌尿器科手術に対する償還プランや財政援助がカバーされ、市場の成長を促進しています。

無料のカスタマイズ提供:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の腎瘻デバイス市場:製品タイプ別

  • 腎瘻カテーテル
  • ガイドワイヤー
  • 拡張器シース
  • 排水チューブ
  • その他の製品タイプ

第6章 世界の腎瘻デバイス市場:エンドユーザー別

  • 外来手術センター
  • 救急診療所
  • 病院
  • その他のエンドユーザー

第7章 世界の腎瘻デバイス市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第8章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第9章 企業プロファイル

  • Angiodynamics Inc
  • Argon Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health
  • Coloplast Group
  • Cook Group(Cook Medical Incorporated)
  • Envaste Limited
  • Medi-Globe GmbH
  • Meditech Devices Pvt Ltd
  • Olympus Corporation
  • Straub Medical AG
  • SURU International Pvt. Ltd
  • Teleflex Incorporated
  • Uresil LLC
図表

List of Tables

  • Table 1 Global Nephrostomy Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 4 Global Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 5 Global Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 6 Global Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 7 Global Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 9 Global Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 10 Global Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 11 Global Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 13 North America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 15 North America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 16 North America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 17 North America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 18 North America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 19 North America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 20 North America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 North America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 22 North America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 23 North America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 North America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 Europe Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 Europe Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 28 Europe Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 29 Europe Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 30 Europe Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 31 Europe Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 32 Europe Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 33 Europe Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 34 Europe Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 35 Europe Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 Europe Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 40 Asia Pacific Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 41 Asia Pacific Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 42 Asia Pacific Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 43 Asia Pacific Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 44 Asia Pacific Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 Asia Pacific Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 46 Asia Pacific Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 47 Asia Pacific Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Asia Pacific Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 South America Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 South America Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 52 South America Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 53 South America Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 54 South America Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 55 South America Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 56 South America Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 57 South America Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 58 South America Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 59 South America Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 South America Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Middle East & Africa Nephrostomy Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Nephrostomy Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Nephrostomy Devices Market Outlook, By Nephrostomy Catheters (2021-2030) ($MN)
  • Table 64 Middle East & Africa Nephrostomy Devices Market Outlook, By Guidewires (2021-2030) ($MN)
  • Table 65 Middle East & Africa Nephrostomy Devices Market Outlook, By Dilators Sheaths (2021-2030) ($MN)
  • Table 66 Middle East & Africa Nephrostomy Devices Market Outlook, By Drainage Tubes (2021-2030) ($MN)
  • Table 67 Middle East & Africa Nephrostomy Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 68 Middle East & Africa Nephrostomy Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Middle East & Africa Nephrostomy Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 70 Middle East & Africa Nephrostomy Devices Market Outlook, By Emergency Clinics (2021-2030) ($MN)
  • Table 71 Middle East & Africa Nephrostomy Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Middle East & Africa Nephrostomy Devices Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC23808

According to Stratistics MRC, the Global Nephrostomy Devices Market is accounted for $1500.5 million in 2023 and is expected to reach $2887.1 million by 2030 growing at a CAGR of 9.8% during the forecast period. To drain urine from the kidney, a thin, flexible tube called a nephrostomy tube is inserted through the skin. The tube is utilized to temporarily discharge obstructed pee. A plastic bag is connected to the tube outside the body to collect the fluid. Nephrostomies can help keep the kidneys healthy and shield them from injury and infection. A nephrostomy device can also aid in the diagnosis of an underlying issue since the ureter can be seen using ultrasonography, X-rays, and contrast material injection.

According to the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life.

Market Dynamics:

Driver:

Rising incidence of urological disorders

Increased incidence of urological conditions such as hydronephrosis, kidney stones, urine retention, bladder cancer, and prostate cancer and the rise in percutaneous nephrostomy treatments are the main factors impacting the market throughout the projected period. Furthermore, the geriatric population is more susceptible to chronic illnesses that need long-term care, such as incontinence, digestive difficulties, and chronic ailments. Therefore, a high-impact driver is anticipated to be an increase in the world's senior population. Additionally, the number of urological procedures performed will climb along with the aging population, which drives market growth.

Restraint:

Entailing negative outcomes

One frequent concern is infection at the location where the nephrostomy tube is placed. Healthcare professionals take preventative measures to reduce this risk, including employing sterile procedures during the treatment and giving patients the right care and maintenance instructions. During or after the nephrostomy surgery, bleeding is possible, which can happen in exceptional circumstances and call for additional medical attention. Some individuals may experience an allergic response to the components of the dressing or nephrostomy tube. There may be slight bleeding, discomfort, or pain at the removal site when the nephrostomy tube is no longer required, thus hampering the growth of the market.

Opportunity:

Rise in demand for minimal invasive operations

Over the course of the forecast period, factors like a rise in demand for less invasive operations and technical developments in nephrostomy devices with a high success rate will drive the market. For patients experiencing pain due to kidney obstruction or infections, a nephrostomy can provide significant pain relief by alleviating the pressure and reducing inflammation in the kidney. It also allows the kidney to continue filtering waste and maintaining fluid balance, creating a wide range of opportunities for market growth.

Threat:

Availability of alternative procedures

The availability of alternatives to nephrostomy surgery can affect patient care in both positive and negative ways, as different procedures may be chosen without a careful assessment of the patient's needs and medical condition, which carries both potential risks for their care. This may result in the decision to take an unsuitable course of action, which may provide less than ideal results or cause difficulties. Various factors, including the experience of the healthcare professional and the accessibility of resources, can have a significant impact on the quality of alternative operations.

COVID-19 Impact:

The initial wave of COVID-19 had a substantial influence on the market for nephrostomy devices because of the delays in nephrology-related procedures and consultations brought on by the global lockdown. The COVID-19 outbreak forced urology departments worldwide to restructure care owing to insufficient resources and manpower. However, as the regulations are loosened, the market is anticipated to expand in the years to come as a result of the rise in renal disorders and the increased use of nephrostomy devices.

The guidewires segment is expected to be the largest during the forecast period

The guidewires segment is estimated to have significant growth because of its ability to gain access and aid transit across different luminal structures. A guidewire is an effective instrument. To make the placement of endourological tools during diagnostic or interventional procedures easier, urological guidewires are used. Due to the rise in renal issues and the desire for minimally invasive kidney disease manufacturers, the rising incidence of kidney stone disorders, the frequency of ovarian, bladder, and prostate malignancies, and the rising desire for less invasive surgical treatments are anticipated to raise the need for guidewires during nephrostomy procedures, which is predicted to encourage market expansion.

The ambulatory surgical centers segment is expected to have the highest CAGR during the forecast period

The ambulatory surgical centers segment is anticipated to witness the highest CAGR during the forecast period, as they provide more individualized services and greater results in comparison to hospitals and other healthcare settings. Additionally, ASCs do not have to deal with the issue of treating a variety of diseases and disorders; they can guarantee that patients receive tailored attention with a better patient experience, thus enhancing the growth of the market.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the advantageous reimbursement rules, rising product awareness, the availability of highly qualified physicians, and the existence of established healthcare facilities in the area. In addition to the rapid use of technologically improved medical goods, the rise in the prevalence of kidney stones in the region is expected to increase the demand for nephrostomy devices.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the establishment of medical facilities such as hospitals, clinics, and urology specialty centers. This raises the need for nephrostomy devices by making healthcare services more accessible to those who need nephrostomy surgeries. Additionally, regional governments are enacting laws and launching efforts to upgrade the healthcare system and promote the use of cutting-edge medical technologies. This covers reimbursement plans and financial aid for urological procedures, thus propelling the growth of the market.

Key players in the market:

Some of the key players profiled in the Nephrostomy Devices Market include: Angiodynamics Inc, Argon Medical, B. Braun Melsungen AG., Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Coloplast Group, Cook Group (Cook Medical Incorporated), Envaste Limited, Medi-Globe GmbH, Meditech Devices Pvt Ltd, Olympus Corporation, Straub Medical AG, SURU International Pvt. Ltd, Teleflex Incorporated and Uresil LLC

Key Developments:

In August 2023, Cardinal health launches next generation medical device to improve neonatal feeding, through real-time assessment technology, the NTrainer™ System provides clinicians with the objective data they need to track the progress of an infant in developing pre-feeding skills.

In June 2023, Becton, Dickinson and Company a leading global medical technology company, announced that it has signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS for $540 million.

In May 2023, Argon Strengthens Biopsy Portfolio with SuperCore Advantage™ Instrument. The SuperCore Advantage is a disposable, next generation soft tissue biopsy instrument that provides a superior volume of tissue sample.

Product Types Covered:

  • Nephrostomy Catheters
  • Guidewires
  • Dilators Sheaths
  • Drainage Tubes
  • Other Product Types

End Users Covered:

  • Ambulatory Surgical Centers
  • Emergency Clinics
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nephrostomy Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Nephrostomy Catheters
  • 5.3 Guidewires
  • 5.4 Dilators Sheaths
  • 5.5 Drainage Tubes
  • 5.6 Other Product Types

6 Global Nephrostomy Devices Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Surgical Centers
  • 6.3 Emergency Clinics
  • 6.4 Hospitals
  • 6.5 Other End Users

7 Global Nephrostomy Devices Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Angiodynamics Inc
  • 9.2 Argon Medical
  • 9.3 B. Braun Melsungen AG
  • 9.4 Becton, Dickinson and Company
  • 9.5 Boston Scientific Corporation
  • 9.6 Cardinal Health
  • 9.7 Coloplast Group
  • 9.8 Cook Group (Cook Medical Incorporated)
  • 9.9 Envaste Limited
  • 9.10 Medi-Globe GmbH
  • 9.11 Meditech Devices Pvt Ltd
  • 9.12 Olympus Corporation
  • 9.13 Straub Medical AG
  • 9.14 SURU International Pvt. Ltd
  • 9.15 Teleflex Incorporated
  • 9.16 Uresil LLC